1. Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni .
- Author
-
Lobo de Sá FD, Backert S, Nattramilarasu PK, Mousavi S, Sandle GI, Bereswill S, Heimesaat MM, Schulzke JD, and Bücker R
- Subjects
- Animals, Campylobacter Infections microbiology, Campylobacter jejuni isolation & purification, Epithelial Cells immunology, Epithelial Cells metabolism, Epithelial Cells pathology, Humans, Intestinal Mucosa immunology, Intestinal Mucosa metabolism, Intestinal Mucosa pathology, Mice, Mice, Inbred C57BL, Mice, Knockout, Tight Junction Proteins metabolism, Vitamins pharmacology, Campylobacter Infections complications, Cell Membrane Permeability, Epithelial Cells drug effects, Interleukin-10 physiology, Intestinal Mucosa drug effects, Vitamin D pharmacology
- Abstract
Infections by the zoonotic foodborne bacterium Campylobacter jejuni ( C. jejuni ) are among the most frequent causes of bacterial gastroenteritis worldwide. The aim was to evaluate the relationship between epithelial barrier disruption, mucosal immune activation, and vitamin D (VD) treatment during C. jejuni infection, using intestinal epithelial cells and mouse models focused on the interaction of C. jejuni with the VD signaling pathway and VD treatment to improve C. jejuni -induced barrier dysfunction. Our RNA-Seq data from campylobacteriosis patients demonstrate inhibition of VD receptor (VDR) downstream targets, consistent with suppression of immune function. Barrier-preserving effects of VD addition were identified in C. jejuni -infected epithelial cells and IL-10
-/- mice. Furthermore, interference of C. jejuni with the VDR pathway was shown via VDR/retinoid X receptor (RXR) interaction. Paracellular leakiness of infected epithelia correlated with tight junction (TJ) protein redistribution off the TJ domain and apoptosis induction. Supplementation with VD reversed barrier impairment and prevented inhibition of the VDR pathway, as shown by restoration of transepithelial electrical resistance and fluorescein (332 Da) permeability. We conclude that VD treatment restores gut epithelial barrier functionality and decreases bacterial transmigration and might, therefore, be a promising compound for C. jejuni treatment in humans and animals.- Published
- 2021
- Full Text
- View/download PDF